Survey 2006 2013 P
  N=416 % N=342 %
Modalities of HCV treatment
Never treated 164 42 130 38 0.71
Previously treated or ongoing treatment 227  58 210 62 0.07
Unknown 25  - 2 - < 0.001
Modalities of the last HCV treatment
Peg-IFN plus ribavirin 167 80 161 88 0.056
Peg-IFN plus ribavirin plus boceprevir - - 11 6 .
Peg-IFN plus ribavirin plus telaprevir - - 12 6 .
Virological response to HCV treatment
Sustained virological response 50 30 80 50 < 0.001
Non virological response 73 44 49 31 0.016
Virological relapse/breakthrough 44 26 30 19 0.11
Missing - - 34 - .
Anti-depressant use 77 20 8 2 < 0.001
Erythropoietin use 27 7 16 5 0.34
Table 3: Modalities and virological results of HCV treatment in HIV-HCV co-infected patients in the 2006 and 2013 surveys.